{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-25-006186","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.777334+00:00","generated_at":"2026-05-21T01:59:51.610012+00:00","sec_items":["2.01","1.01","2.03","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Royalty Pharma closes acquisition of RP LLC; $200M cash, shares, and $380M debt assumed","bullets":["Paid $200M cash plus 24,530,266 non-voting Class E shares; assumed RP Management's $380M term loan.","Share consideration to Pablo Legorreta vests over 5 years; other management members vest over 10 years.","Joinder of Royalty Pharma Holdings Ltd and RP LLC as borrowers under existing $380M term loan; RP Management released.","Amended exchange agreement allows recipients to exchange RPH non-voting shares for Royalty Pharma Class A shares.","Amended articles of association of Royalty Pharma plc and RPH to reflect new share classes and procedural refinements."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-25-006186","json":"https://secwatch.observer/filing/0000950103-25-006186.json","markdown":"https://secwatch.observer/filing/0000950103-25-006186.md","text":"https://secwatch.observer/filing/0000950103-25-006186.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000095010325006186/0000950103-25-006186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000095010325006186/dp228958_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T01:59:51.610012+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}